© 2025 CUA All Rights Reserved
Contact
486 Chemin Bord du Lac
Dorval, Quebec H9S 2A8
corporate.office@cua.org
Menu
Menu
Dr. Bhojani was born and raised in Montreal. He obtained a BSc in microbiology and immunology and another in physiotherapy from McGill University in 2001, and then completed medical school and urology residency at the University of Montreal.
In 2011, Dr. Bhojani spent two years with Dr. Lingeman at Indiana University, completing his fellowship in BPH and stone disease.
Dr. Bhojani was recruited by the University of Montreal in 2013 to build and develop comprehensive kidney stone and BPH programs. At the University of Montreal, he has the rank of Full Professor and Clinical Researcher.
Dr. Bhojani has published >250 articles on stone disease and BPH and is an editorial board member of the Journal of Endourology, Urology Practice, and associate editor for the Canadian Urological Association Journal. In 2017, Dr. Bhojani was named the AUA’s Young Urologist of the Year, representing the NSAUA, and in 2019, Dr. Bhojani was awarded the prestigious Clinical Research Scholar Award from the FRQ-S.
Dr. Chung is an Associate Professor at the Zucker School of Medicine at Hofstra/Northwell. She has an extensive specialization in urinary incontinence, pelvic organ prolapse, neurourology, overactive bladder, benign prostatic hyperplasia (BPH), and complex genitourinary reconstruction.
Dr. Chung completed her medical education and residency in urology at the University of Toronto, followed by a fellowship in female urology, voiding dysfunction, and reconstructive surgery at Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center in New York. After her fellowship, she served on the faculty at the University of Chicago and Columbia University before joining Northwell Health in 2025.
Her contributions to the field have been recognized by numerous awards, including the Castle Connolly and New York Magazine Best Doctors award since 2019, and New York Magazine’s Exceptional Women in Medicine Award. She is instrumental in establishing and updating clinical guidelines and has had significant involvement with the American Urological Association, notably helping to develop their overactive bladder guidelines.
Dr. Chung is an avid researcher with over 40 peer-reviewed publications and is actively engaged in outcomes research focusing on areas such as the impact of diabetes on bladder function and the efficacy of sling procedures. She is also involved in investigating the use of social media for patient education and has investigated outcomes of botulinum toxin injections for bladder treatments.
Dr. Fentie is a Professor of Surgery at the University of Saskatchewan and has worked in a community urology practice in Saskatoon from 1985.
He completed pre-medicine and MD degrees at the University of Alberta, graduating in 1979. This was followed by a one-year internship at Royal Jubilee Hospital in Victoria, BC and urology residency at the University of Alberta. He has been a member of the Fellowship of the Royal College of Surgeons since 1984.
Dr. Hsi is an Associate Professor of Urology at the University of California, Irvine. His research focuses on improving the prevention, diagnosis, and management of kidney stones through clinical trials, health services research, and data-driven innovations. He is the principal investigator for multiple NIH-funded studies, including projects to optimize kidney stone prevention and to develop national research networks for urinary stone disease. He is the 2025 recipient of the American Urological Association’s Gold Cystoscope Award. He is also deeply dedicated to education and mentorship, having received multiple resident teaching awards and trained numerous residents and fellows.
Dr. Khoury is a Professor in the Department of Urology and the Head of Pediatric Urology at both The Children’s Hospital of Orange County and the University of California Irvine Medical Center.
Before joining the University of California and CHOC Children’s, Dr. Khoury was the Chief of Pediatric Urology at the Hospital for Sick Children in Toronto. He is internationally recognized for his expertise in the surgical management of complex pediatric urology anomalies, including reconstructive surgery for incontinence, genital anomalies, renal transplantation and oncology.
Dr. Khoury has trained more than 50 fellows in pediatric urology, many of whom are academic leaders nationally and internationally. He has more than 250 peer-reviewed publications and 60 book chapters and is the co-editor of the standard textbook in pediatric urology, “Clinical Pediatric Urology.” He is the Past President of the Pediatric Urologists of Canada and has served on the executive boards of the Canadian Urological Association, the American Academy of Pediatrics, Section on Urology, and the ICCS. He has also been elected to membership in the AAGUS and SPUS.
Dr. McCammon serves as the Devine Chair in Genitourinary Reconstructive Surgery, Chairman and Professor of the Department of Urology at Eastern Virginia Medical School (EVMS), Program Director of Urologic Residency and Adult and Pediatric Genitourinary Reconstructive Surgery Fellowship.
He received his medical degree from the Medical College of Ohio, followed by a urology residency at EVMS and a two-year fellowship in GU reconstruction at EVMS.
He is the Past Mid-Atlantic Representative on the board of the AUA, Past President of GURS, Past Chair of the IVUmed Board, and Past Chair of Education for the Société Internationale d’Urologie. He currently serves on the UCF Board. Dr. McCammon is a Diplomate of the American Board of Urology.
He is honored to have received the Distinguished Alumnus Award from the University of Toledo in October 2011, the Christina Manthos Mentoring Award from the Society of Women in Urology in 2017, and the SIU Albert Schweitzer International Teaching Award in 2022.
Dr. McCammon lectures both nationally and internationally on the topics of male and female reconstruction and has authored numerous chapters and publications on pelvic reconstruction. His clinical interests include female urology, pelvic reconstruction, urethral reconstruction, male incontinence, global surgical education, and humanitarian medicine.
Dr. Pippi Salle is a Professor at the Division of Urology, SickKids Hospital, and Co-Director of the Center for Pelvic Reconstruction. He was the former Chief of Urology of the Montreal Children’s Hospital, Toronto SickKids Hospital in Canada, and Sidra Medicine in Doha, Qatar.
He is a pediatric urologist with a special interest in genitourinary reconstruction. He is an innovative surgeon who developed new techniques for the correction of refractory urinary incontinence, disorders of sex development, hypospadias, exstrophy/epispadias complex, and UPJ obstruction.
He has published 193 papers and 55 book chapters. He was a visiting professor in 41 countries and associated editor of the textbook Clinical Pediatric Urology, one of the most prestigious in the specialty, as well as co-editor of the book Bladder Exstrophy. He is an accomplished teacher, having received several teaching awards at the University of Toronto and McGill University. He was the inaugural Women’s Auxiliary Chair of Urology at SickKids Hospital in Toronto and is proud of having trained many of the world-leading pediatric urologists.
In 2019, Dr. Pippi Salle received the Life Achievement Award from the World Federation of Pediatric Surgeons (WOFAPS) in recognition of his academic contributions to pediatric urology worldwide. In 2024, he was the recipient of the Humanitarian Award given by the American Bladder Exstrophy Association, as well as the Wee-Willies Award from the American Association of Pediatric Urologists.
Dr. Ribal was a member of the Oncology Unit in the Department of Urology at Fundació Puigvert from 2002 to 2005. Since February 2005, she has been a member of the Department of Urology at Hospital Clínic of Barcelona, where she was appointed Head of the Multidisciplinary Uro-Oncology Unit in December 2011. This unit integrates urology, medical oncology, radiotherapy, and other specialties to deliver comprehensive care for patients with urologic cancers.
She has also held an academic position as Associate Professor of Surgery at the University of Barcelona since 2005. From April 2018 to November 2022, she served as President of the Catalan Society of Urology.
Dr. Ribal obtained her medical degree in 1994 and her PhD in 2002, both from the University of Barcelona. She completed her residency in urology at Hospital Clínic of Barcelona in 1999 and went on to conduct a research fellowship supported by an investigation grant at the same institution (2000–2001). In 2002, she served as a Visiting Clinician at the Mayo Clinic in Rochester, U.S., and later completed a laparoscopic surgery fellowship at University College London Hospital (UCLH) in 2006.
Her main areas of interest include urologic oncology, major oncologic and laparoscopic surgery, kidney transplantation, and genetic research in urologic tumors. She is the author of over 200 scientific publications and has delivered more than 350 invited lectures at national and international conferences and educational events.
Dr. Ribal has been actively involved in the European Association of Urology (EAU), serving as a member of the Muscle-Invasive and Metastatic Bladder Cancer Guidelines Panel from 2006 to 2020, and as a Board Member of the EAU Section of Urological Research (EUSP) from 2012 to 2020. She chaired the Dissemination Committee of the EAU Guidelines between 2016 and 2021, has been a member of the EAU Guidelines Office Board since 2016, and served as Vice-Chair from 2019.
In July 2021, she became Chair of the EAU Guidelines Office, marking the first time a woman has held this position on the EAU Board.
In recognition of her achievements and potential, Dr. Ribal received the EAU’s Crystal Matula Award in 2009, the most prestigious distinction awarded to a young European urologist.
Dr. Rubin is a nationally recognized, board-certified urologist with fellowship training in sexual medicine and the founder of a patient-centered sexual health practice in Washington, D.C., and an Assistant Clinical Professor of Urology at Georgetown University.
A clinician, researcher, and passionate educator, Dr. Rubin provides comprehensive, multidisciplinary care to patients of all ages and genders, treating conditions that affect arousal, orgasm, libido, pelvic and genital pain, erectile dysfunction, and menopause.
She is the former Education Chair and current Director-at-Large for the International Society for the Study of Women’s Sexual Health (ISSWSH), and she serves on the editorial boards of the Journal of Sexual Medicine and the Video Journal of Sexual Medicine. Dr. Rubin most recently played a key role in the development of the American Urological Association’s clinical guidelines for genitourinary syndrome of menopause (GSM) and was instrumental in the removal of the FDA’s black box labeling on menopausal hormone therapy.
Dr. Shayegan is an Associate Professor of Surgery at McMaster University. He is currently the Division Head of Urology at McMaster University and Chief of Surgery and Head of CCO Surgical Oncology at St. Joseph’s Healthcare Hamilton. He also serves as Chair of the Robotic Surgical Program.
He completed his MD and residency at the University of Toronto. He subsequently pursued a comprehensive fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center in New York City and joined the Division of Urology at McMaster in 2006.
Dr. Shayegan’s clinical research interests include minimally invasive techniques in urologic oncology and treatment of advanced prostate cancer.
Dr. Walz is an Assistant Professor and Head of Urology at the Institut Paoli-Calmettes Cancer Centre in Marseille, France.
He obtained his medical degree from the University of Mainz in Germany, followed by a urology residency at the University of Hamburg in Germany and in Marseille, France. He went on to do a research fellowship at the Cancer Prognostics and Health Outcomes Unit at the University of Montreal. He also holds a Master of Arts in management of healthcare institutions
Dr. Walz is the Editor-in-Chief of European Urology Open Science, a member of the EAU Scientific Office, former Chairman of the EAU Section of Urological Imaging (ESUI), Co-coordinator of ESMO prostate cancer guidelines, and a liaison officer between the EAU and EANM.
His research interests include prostate cancer imaging and diagnosis, prediction tools, and treatment of advanced and localized prostate cancer.
Contact
486 Chemin Bord du Lac
Dorval, Quebec H9S 2A8
corporate.office@cua.org